Join the Adderall XR group to help and get support from people like you.
Adderall XR News
Rx Amphetamine Use Linked to Increased Odds of Psychosis, Mania
TUESDAY, Sept. 17, 2024 – Past-month prescription amphetamine use is associated with increased odds of psychosis and mania, with increased odds for high doses (>30 mg dextroamphetamine equivalents),...
High Doses of ADHD Meds Could Trigger Psychosis
THURSDAY, Sept. 12, 2024 – Prescriptions for amphetamine stimulants to treat ADHD have increased significantly in recent years, particularly during the pandemic. Unfortunately, high doses of...
ADHD Meds Tied to Heart Damage in Young Adult Users
WEDNESDAY, March 27, 2024 – ADHD stimulant medications like Ritalin or Adderall appear linked to a heightened risk for cardiomyopathy (a weakening of the heart muscle), and the risk grows with time,...
Taking 'Study Drugs' Like Adderall Could Be Gateway to More Drug Abuse
THURSDAY, March 14, 2024 – College students who use drugs like Adderall to help them focus on their studies may be setting themselves up for trouble. Researchers asked 700 undergraduates across the...
In Utero Rx Stimulant Exposure Not Tied to Later Neurodevelopmental Issues
THURSDAY, Feb. 1, 2024 --Amphetamine/dextroamphetamine and methylphenidate exposure in utero does not appear to increase the risk for childhood neurodevelopmental disorders, according to a study...
FDA Medwatch Alert: FDA Updating Warnings to Improve Safe Use of Prescription Stimulants Used to Treat ADHD and Other Conditions
What safety concern is FDA announcing? To address continuing concerns of misuse, abuse, addiction, and overdose of prescription stimulants, the U.S. Food and Drug Administration (FDA) is requiring...
FDA Approves Mydayis (mixed salts of a single-entity amphetamine product) – A New Once-Daily Option for ADHD
Lexington, Mass., USA – June 20, 2017 – Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the U.S. Food and Drug Administration (FDA) has approved Mydayis (mixed salts of a single-entity amp...
FDA Medwatch Alert: Teva's Adderall 30 mg Tablets: Counterfeit Product - Contains Wrong Active Ingredients
ISSUE: FDA is warning consumers and health care professionals about a counterfeit version of Teva Pharmaceutical Industries' Adderall 30 milligram tablets that is being purchased on the Internet....
FDA Medwatch Alert: Adderall XR (amphetamine)
FDA issued a Public Health Advisory to notify healthcare professionals that Health Canada, the Canadian drug regulatory agency, has suspended the sale of Adderall XR in the Canadian market. Adderall...
Further information
Related condition support groups
Attention-Deficit Hyperactivity Disorder (ADHD)